Improving PET imaging for better understanding of blood flow and metabolism in diseases
Single-tracer Multiparametric PET Imaging
This study is working on improving PET scans to better measure blood flow and how cells use energy in one go, which could help patients with conditions like cancer and brain disorders get more accurate diagnoses and treatment plans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10880343 on NIH RePORTER |
What this research studies
This research focuses on enhancing PET imaging techniques to simultaneously assess blood flow and cellular metabolism using a single radiotracer, 18F-FDG. By developing a method that eliminates the need for a second tracer, the study aims to improve the accuracy and utility of PET imaging in various diseases, including cancer and neurodegenerative disorders. Patients may benefit from more precise imaging that can lead to better diagnosis and treatment planning. The research involves advanced imaging technology and analysis to address current limitations in flow-metabolism imaging.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with neurodegenerative diseases, cancer, or cardiac conditions who require advanced imaging techniques.
Not a fit: Patients who do not have conditions affecting blood flow or metabolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and treatment strategies for patients with conditions like cancer and Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using single-tracer techniques for imaging, but this specific approach is innovative and aims to overcome existing challenges.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Wang, Guobao — University of California at Davis
- Study coordinator: Wang, Guobao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.